Zobrazeno 1 - 5
of 5
pro vyhledávání: '"J A Silvennoinen"'
Autor:
R. A. Karttunen, P O Väre, J. A. Silvennoinen, Seppo Niemelä, B. Heikius, Juhani Lehtola, Tuomo J. Karttunen
Publikováno v:
Scandinavian Journal of Gastroenterology. 36:1295-1300
The mechanisms for the observed low prevalence of Helicobacter pylori infection in inflammatory bowel disease (IBD) are unknown, but might be important for the pathogenesis of IBD. We have studied the seroprevalence of H. pylori in different categori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d7cb661b6ec0d1c8e68364527003b2
https://doi.org/10.1080/003655201317097155
https://doi.org/10.1080/003655201317097155
Publikováno v:
Scandinavian Journal of Rheumatology. 27:188-193
52 patients with early rheumatoid arthritis (RA) were followed with regular measurements of bone mineral density (BMD) and serum markers of type I collagen metabolism in order to determine whether they develop osteoporosis during the first two years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc0b824948685c7c95cdfaa2b426dab8
https://doi.org/10.1080/030097498440796
https://doi.org/10.1080/030097498440796
Publikováno v:
Scandinavian Journal of Gastroenterology. 31:367-371
Some patients with inflammatory bowel disease have reduced bone mineral density, but the risk factors for osteoporosis in these patients are unclear.To evaluate the effect of smoking and other lifestyle factors on bone mineral density in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b3ad0d5781a0d104110928701110003
https://doi.org/10.3109/00365529609006412
https://doi.org/10.3109/00365529609006412
Publikováno v:
Gut. 37:71-76
To assess the prevalence of and risk factors for low bone mineral density in inflammatory bowel disease (IBD), 152 IBD patients and 73 healthy controls were studied. Sixty seven patients had ulcerative colitis, 78 had Crohn's disease (52 of them (66.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71352f9293cfe8af19d570bb9a4fc9c
https://doi.org/10.1136/gut.37.1.71
https://doi.org/10.1136/gut.37.1.71
Publikováno v:
Scopus-Elsevier
To assess the mechanisms of osteopenia in inflammatory bowel disease (IBD), the serum markers of bone formation (osteocalcin and carboxyterminal propeptide of type I procollagen (PICP)) and bone degradation (carboxyterminal telopeptide of type I coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e37e9ff16c497d353fb2b31d2cf28d
https://europepmc.org/articles/PMC1383027/
https://europepmc.org/articles/PMC1383027/
